Multiple sclerosis: Serum anti-CNS autoantibodies - John W Prineas
Por um escritor misterioso
Descrição
Multiple Sclerosis: Mechanisms and Immunotherapy - ScienceDirect
Frontiers B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
Multiple sclerosis: Serum anti-CNS autoantibodies - John W Prineas, John D.E Parratt, 2018
John PRINEAS, Professor (Honorary), AO MBBS MD FRCP FRCPEdin, The University of Sydney, Sydney, Discipline of Medicine
Therapy in clinical practice (Section IV) - Multiple Sclerosis Therapeutics
PDF) Defining distinct features of anti-MOG antibody associated central nervous system demyelination
Frontiers Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome
Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression
PDF) Multiple Sclerosis: New Aspects of Immunopathogenesis
Immunoglobulins and complement in postmortem multiple sclerosis tissue - Barnett - 2009 - Annals of Neurology - Wiley Online Library
Smouldering multiple sclerosis: the 'real MS' - Gavin Giovannoni, Veronica Popescu, Jens Wuerfel, Kerstin Hellwig, Ellen Iacobaeus, Michael B. Jensen, José Manuel García-Domínguez, Livia Sousa, Nicola De Rossi, Raymond Hupperts, Giuseppe Fenu
Multiple Sclerosis: Current Pathophysiological Concepts
Frontiers Aquaporin-4 Autoantibodies From Neuromyelitis Optica Spectrum Disorder Patients Induce Complement-Independent Immunopathologies in Mice
A backpack-based myeloid cell therapy for multiple sclerosis
de
por adulto (o preço varia de acordo com o tamanho do grupo)
